Upgrade to SI Premium - Free Trial

Mirum Pharmaceuticals, Inc. (MIRM)

93.48 +0.99 (1.07%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Mirum and Incyte to present zilurgisertib study results at ENDO 2026 June 4, 2026 8:06 AM - StreetInsider Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026 June 4, 2026 8:05 AM - BizWire Form 4 Mirum Pharmaceuticals, For: Jun 01 Filed by: Peetz Christopher June 2, 2026 7:50 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: May 29 Filed by: Cardon Lon June 2, 2026 7:50 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: May 29 Filed by: Fischer Laurent June 2, 2026 7:50 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: May 29 Filed by: Walbert Timothy P June 2, 2026 7:50 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: May 29 Filed by: Ramasastry Saira June 2, 2026 7:50 PM - SEC Filing Citi Starts Mirum Pharmaceuticals (MIRM) at Buy June 2, 2026 5:01 AM - StreetInsider Form 144 Mirum Pharmaceuticals, Filed by: Peetz Christopher June 1, 2026 5:33 PM - SEC Filing Form 144 Mirum Pharmaceuticals, Filed by: Ramasastry Saira June 1, 2026 4:05 PM - SEC Filing Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens June 1, 2026 4:43 AM - StreetInsider Mirum presents new data on rare liver disease treatments at EASL congress June 1, 2026 2:53 AM - StreetInsider Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026 May 30, 2026 12:00 PM - BizWire JPMorgan says large-cap biotech is back as profits and pipelines fuel upside May 28, 2026 4:07 PM - StreetInsider Mirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026 May 21, 2026 8:05 AM - BizWire JPMorgan Reinstates Mirum Pharmaceuticals (MIRM) at Overweight May 20, 2026 4:31 AM - StreetInsider Wolfe Research Starts Mirum Pharmaceuticals (MIRM) at Outperform May 19, 2026 5:32 AM - StreetInsider Form 4 Mirum Pharmaceuticals, For: May 15 Filed by: Ramasastry Saira May 18, 2026 8:33 PM - SEC Filing Form 8-K Mirum Pharmaceuticals, For: May 12 May 18, 2026 4:06 PM - SEC Filing Form 144 Mirum Pharmaceuticals, Filed by: Ramasastry Saira May 15, 2026 4:13 PM - SEC Filing Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 14, 2026 4:01 PM - BizWire Mirum Pharmaceuticals prices $600 million convertible notes offering May 12, 2026 11:56 PM - StreetInsider Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes May 12, 2026 11:56 PM - BizWire Mirum announces $600 million convertible notes offering due 2032 May 12, 2026 4:01 PM - StreetInsider Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering May 12, 2026 4:01 PM - BizWire Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences May 12, 2026 8:00 AM - BizWire Mirum Pharmaceuticals (MIRM) PT Raised to $185 at H.C. Wainwright May 8, 2026 7:00 AM - StreetInsider Mirum Pharmaceuticals (MIRM) PT Raised to $145 at TD Cowen May 7, 2026 8:50 AM - StreetInsider Mirum Pharmaceuticals (MIRM) PT Raised to $142 at RBC Capital May 7, 2026 8:30 AM - StreetInsider Mirum Pharmaceuticals (MIRM) PT Raised to $136 at Stifel May 7, 2026 7:31 AM - StreetInsider Mirum Pharmaceuticals (MIRM) PT Raised to $129 at Baird May 7, 2026 4:28 AM - StreetInsider Mirum Pharmaceuticals, Inc. (MIRM) Misses Q1 EPS by 1309c ; Offers Guidance May 6, 2026 4:20 PM - StreetInsider Form 10-Q Mirum Pharmaceuticals, For: Mar 31 May 6, 2026 4:08 PM - SEC Filing Form 8-K Mirum Pharmaceuticals, For: May 06 May 6, 2026 4:05 PM - SEC Filing Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update May 6, 2026 4:01 PM - BizWire Mirum Pharmaceuticals (MIRM) PT Raised to $140 at Morgan Stanley May 5, 2026 8:01 AM - StreetInsider Mirum Pharmaceuticals (MIRM) PT Raised to $175 at H.C. Wainwright May 5, 2026 7:33 AM - StreetInsider Baird Reiterates Outperform Rating on Mirum Pharmaceuticals (MIRM) May 4, 2026 9:41 AM - StreetInsider Mirum Pharmaceuticals (MIRM) PT Raised to $135 at Evercore ISI May 4, 2026 8:45 AM - StreetInsider Mirum reports volixibat meets primary endpoint in cholangitis study May 4, 2026 8:01 AM - StreetInsider Form 8-K Mirum Pharmaceuticals, For: May 04 May 4, 2026 8:00 AM - SEC Filing Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis May 4, 2026 8:00 AM - BizWire Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026 May 3, 2026 5:00 PM - BizWire Mirum Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026 April 29, 2026 4:01 PM - BizWire Mirum Pharmaceuticals (MIRM) PT Raised to $130 at Stifel April 28, 2026 5:05 PM - StreetInsider Form SCHEDULE 13G/A Mirum Pharmaceuticals, Filed by: BlackRock, Inc. April 27, 2026 4:14 PM - SEC Filing Mirum Pharmaceuticals (MIRM) PT Raised to $112 at Baird April 27, 2026 11:21 AM - StreetInsider Mirum Pharmaceuticals (MIRM) PT Raised to $150 at H.C. Wainwright April 27, 2026 10:02 AM - StreetInsider Form 8-K Mirum Pharmaceuticals, For: Apr 27 April 27, 2026 8:08 AM - SEC Filing MIRUM meets primary endpoint in hepatitis delta drug trial April 27, 2026 8:00 AM - StreetInsider Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus April 27, 2026 8:00 AM - BizWire Form ARS Mirum Pharmaceuticals, For: Dec 31 April 24, 2026 9:58 AM - SEC Filing Form DEF 14A Mirum Pharmaceuticals, For: Dec 31 April 23, 2026 7:21 PM - SEC Filing Form DEFA14A Mirum Pharmaceuticals, April 23, 2026 7:21 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: Apr 15 Filed by: Ramasastry Saira April 16, 2026 8:40 PM - SEC Filing Form 144 Mirum Pharmaceuticals, Filed by: Ramasastry Saira April 15, 2026 4:12 PM - SEC Filing Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 13, 2026 4:01 PM - BizWire Bernstein on US Pharma and Biotech: Who might buy whom? April 13, 2026 5:52 AM - StreetInsider Mirum Pharmaceuticals (MIRM) Reiterated at Overweight by Cantor Fitzgerald April 10, 2026 8:01 AM - StreetInsider Form 8-K/A Mirum Pharmaceuticals, For: Jan 23 April 8, 2026 4:14 PM - SEC Filing Form SCHEDULE 13G/A Mirum Pharmaceuticals, Filed by: VANGUARD GROUP INC March 27, 2026 10:53 AM - SEC Filing Mirum Pharmaceuticals (MIRM) PT Raised to $125 at TD Cowen March 27, 2026 6:24 AM - StreetInsider Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens March 26, 2026 4:41 AM - StreetInsider Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens March 23, 2026 8:12 AM - StreetInsider Form 4 Mirum Pharmaceuticals, For: Mar 15 Filed by: Quan Joanne March 17, 2026 7:30 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: Mar 15 Filed by: Radovich Peter March 17, 2026 7:30 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: Mar 15 Filed by: BJERKHOLT ERIC March 17, 2026 7:30 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: Mar 16 Filed by: Ramasastry Saira March 17, 2026 7:30 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: Mar 15 Filed by: Peetz Christopher March 17, 2026 7:30 PM - SEC Filing Form 4 Mirum Pharmaceuticals, For: Mar 15 Filed by: Howe Jolanda March 17, 2026 7:30 PM - SEC Filing Form 144 Mirum Pharmaceuticals, Filed by: BJERKHOLT ERIC March 17, 2026 7:03 PM - SEC Filing Form 144 Mirum Pharmaceuticals, Filed by: Quan Joanne March 17, 2026 7:01 PM - SEC Filing Form 144 Mirum Pharmaceuticals, Filed by: Radovich Peter March 17, 2026 6:58 PM - SEC Filing Form 144 Mirum Pharmaceuticals, Filed by: Howe Jolanda March 17, 2026 6:55 PM - SEC Filing Form 144 Mirum Pharmaceuticals, Filed by: Peetz Christopher March 17, 2026 6:50 PM - SEC Filing Citizens Reiterates Market Outperform Rating on Mirum Pharmaceuticals (MIRM) March 17, 2026 5:30 AM - StreetInsider Form 144 Mirum Pharmaceuticals, Filed by: Ramasastry Saira March 16, 2026 4:06 PM - SEC Filing Mirum Pharmaceuticals completes enrollment in liver disease drug study March 16, 2026 8:00 AM - StreetInsider Mirum Pharmaceuticals Completes Enrollment in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Additional Rare Cholestatic Liver Diseases March 16, 2026 8:00 AM - BizWire Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 12, 2026 5:30 PM - BizWire Form 4 Mirum Pharmaceuticals, For: Mar 06 Filed by: Radovich Peter March 11, 2026 4:06 PM - SEC Filing Full Article List